{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T05:14:34Z","timestamp":1739855674883,"version":"3.37.3"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Xingtai Science and Technology Burea","award":["2024ZC137"],"award-info":[{"award-number":["2024ZC137"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,2,14]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Motion sickness is frequently encountered condition, characterized primarily by symptoms such as nausea, vomiting, headache, dizziness, and drowsiness. Autoimmune encephalitis refers to a group of diseases that can present with a variety of clinical symptoms according to the expressed autoantigen. One of the rare types is myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). Herein, we report the case of a child who presented to our otolaryngology department with a diagnosis of motion sickness but was eventually diagnosed with MOGAD. To our knowledge, this is the first such case reported in the literature.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>An 11-year-old boy presented to a vertigo clinic with the primary complaints of dizziness, occasional nausea, and vomiting after traveling with his family for 3 days. He was diagnosed with motion sickness and was administered oral betastine mesylate tablets (6\u2009mg, 3 times\/d for 3 days). The dizziness resolved after 3 days of medication. However, 1 week later, the child developed symptoms of vision loss, poor mental performance, and sluggish responses.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>The patient was diagnosed with MOGAD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The patient was treated with human immunoglobulin (2\u2009g\/kg, divided into 3 doses), mannitol, and a high dose of methylprednisolone succinate (20\u2009mg\/kg for 3 consecutive days). The dose of methylprednisolone succinate was then gradually tapered over 18 days.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>After 15 days of treatment, the child\u2019s vision in the left eye improved, with visual acuity returned to 0.25. His sense of taste and pain in the left limb returned to normal, his mental responses were good, and no antinuclear antibodies were detectable.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>Although most childhood episodes of dizziness are benign, it is important for clinicians to remain vigilant for the possibility of central nervous system disease as the underlying cause. When the diagnosis is uncertain, doctors and parents must closely monitor affected children to avoid misdiagnosis and treatment delays.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000041558","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T19:00:31Z","timestamp":1739818831000},"page":"e41558","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Autoimmune encephalitis with dizziness in children: A case report presented to the otolaryngology department"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7326-3491","authenticated-orcid":false,"given":"Guifang","family":"Li","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Hebei Provincial Eye Hospital, Hebei Provincial Key Laboratory of Ophthalmology, Hebei Provincial Eye Institute, Xingtai, Hebei, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anqi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Hebei Provincial Eye Hospital, Hebei Provincial Key Laboratory of Ophthalmology, Hebei Provincial Eye Institute, Xingtai, Hebei, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinge","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Hebei Provincial Eye Hospital, Hebei Provincial Key Laboratory of Ophthalmology, Hebei Provincial Eye Institute, Xingtai, Hebei, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Hebei Provincial Eye Hospital, Hebei Provincial Key Laboratory of Ophthalmology, Hebei Provincial Eye Institute, Xingtai, Hebei, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinglei","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Hebei Provincial Eye Hospital, Hebei Provincial Key Laboratory of Ophthalmology, Hebei Provincial Eye Institute, Xingtai, Hebei, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yabo","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Hebei Provincial Eye Hospital, Hebei Provincial Key Laboratory of Ophthalmology, Hebei Provincial Eye Institute, Xingtai, Hebei, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanzhuo","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Hebei Provincial Eye Hospital, Hebei Provincial Key Laboratory of Ophthalmology, Hebei Provincial Eye Institute, Xingtai, Hebei, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250217","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.ijporl.2014.02.009","article-title":"Prevalence and diagnosis of vestibular disorders in children: a review.","volume":"78","author":"Gioacchini","year":"2014","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"R2-20250217","first-page":"CD002851","article-title":"Scopolamine (hyoscine) for preventing and treating motion sickness.","volume":"18","author":"Spinks","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"R3-20250217","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00221-011-2993-4","article-title":"Postural activity and motion sickness during video game play in children and adults.","volume":"217","author":"Chang","year":"2012","journal-title":"Exp Brain Res"},{"key":"R4-20250217","doi-asserted-by":"crossref","first-page":"460825","DOI":"10.1155\/2012\/460825","article-title":"Neuromyelitis optica: an antibody-mediated disorder of the central nervous system.","volume":"2012","author":"Oh","year":"2012","journal-title":"Neurol Res Int"},{"key":"R5-20250217","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.msard.2018.07.025","article-title":"MOG antibody disease: a review of MOG antibody seropositive neuromyelitis optica spectrum disorder.","volume":"25","author":"Narayan","year":"2018","journal-title":"Mult Scler Relat Disord"},{"key":"R6-20250217","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.1007\/s00415-020-10026-y","article-title":"Treatment of MOG antibody associated disorders: results of an international survey.","volume":"267","author":"Whittam","year":"2020","journal-title":"J Neurol"},{"key":"R7-20250217","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41582-018-0112-x","article-title":"Myelin oligodendrocyte glycoprotein antibodies in neurological disease.","volume":"15","author":"Reindl","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"R8-20250217","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.autneu.2006.07.019","article-title":"Motion sickness susceptibility.","volume":"129","author":"Golding","year":"2006","journal-title":"Auton Neurosci"},{"key":"R9-20250217","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/B978-0-444-63437-5.00025-X","article-title":"Vertigo and dizziness in children.","volume":"137","author":"Jahn","year":"2016","journal-title":"Handb Clin Neurol"},{"key":"R10-20250217","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s00431-014-2351-1","article-title":"Motion sickness prevalence in school children.","volume":"173","author":"Henriques","year":"2014","journal-title":"Eur J Pediatr"},{"key":"R11-20250217","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.brainresbull.2009.09.017","article-title":"Motion sickness: a negative reinforcement model.","volume":"81","author":"Bowins","year":"2010","journal-title":"Brain Res Bull"},{"key":"R12-20250217","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.otorri.2011.01.005","article-title":"Exploraci\u00f3n vestibular de ni\u00f1os con alteraciones del equilibrio (I): m\u00e9todos de la exploraci\u00f3n cl\u00ednica e instrumental [vestibular examination of children with alterations in balance (I): clinical and instrumental examination methods].","volume":"62","author":"Femia","year":"2011","journal-title":"Acta Otorrinolaringol Esp"},{"key":"R13-20250217","first-page":"687","article-title":"The neurophysiology and treatment of motion sickness.","volume":"115","author":"Koch","year":"2018","journal-title":"Dtsch Arztebl Int"},{"key":"R14-20250217","doi-asserted-by":"crossref","first-page":"5589","DOI":"10.1016\/j.radcr.2024.08.032","article-title":"Extensive brainstem lesions in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a case report.","volume":"19","author":"Kojita","year":"2024","journal-title":"Radiol Case Rep"},{"key":"R15-20250217","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1007\/s10072-023-06919-1","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated disease preceding primary central nervous system lymphoma: causality or coincidence?","volume":"44","author":"Cai","year":"2023","journal-title":"Neurol Sci"},{"key":"R16-20250217","doi-asserted-by":"crossref","first-page":"e31734","DOI":"10.1097\/MD.0000000000031734","article-title":"General anesthesia, using remimazolam, for the patient with myelin oligodendrocyte glycoprotein antibody associated disease (MOGAD): a case report.","volume":"101","author":"Hong","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"R17-20250217","first-page":"e64868","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated disease complicated by pachymeningitis: a case report.","volume":"16","author":"Khaladkar","year":"2024","journal-title":"Cureus"},{"key":"R18-20250217","first-page":"e60612","article-title":"Uncovering the diagnostic challenge of myelin oligodendrocyte glycoprotein antibody-associated disease: a case study of acute bilateral vision loss.","volume":"16","author":"Anto","year":"2024","journal-title":"Cureus"},{"key":"R19-20250217","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00429-010-0266-9","article-title":"Taste representation in the human insula.","volume":"214","author":"Small","year":"2010","journal-title":"Brain Struct Funct"},{"key":"R20-20250217","doi-asserted-by":"crossref","first-page":"885218","DOI":"10.3389\/fneur.2022.885218","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a review of clinical and MRI features, diagnosis, and management.","volume":"13","author":"Sechi","year":"2022","journal-title":"Front Neurol"},{"key":"R21-20250217","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/jamaneurol.2019.2940","article-title":"Serial anti-myelin oligodendrocyte glycoprotein antibody analyses and outcomes in children with demyelinating syndromes.","volume":"77","author":"Waters","year":"2020","journal-title":"JAMA Neurol"},{"key":"R22-20250217","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S1474-4422(19)30488-0","article-title":"Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study.","volume":"19","author":"Armangue","year":"2020","journal-title":"Lancet Neurol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041558","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T19:00:41Z","timestamp":1739818841000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,14]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000041558","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,14]]}}}